cobas BKV, cobas EBV/BKV Control Kit, cobas Buffer Negative Control Kit
K-Number: K202215 · 2020-09-02
Device Summary
Frequently Asked Questions
What is the cobas BKV, cobas EBV/BKV Control Kit, cobas Buffer Negative Control Kit?
cobas BKV, cobas EBV/BKV Control Kit, cobas Buffer Negative Control Kit is a medical device that received FDA 510(k) clearance on 2020-09-02. The listed applicant is Roche Molecular Systems, Inc.. The 510(k) number is K202215.
When did cobas BKV, cobas EBV/BKV Control Kit, cobas Buffer Negative Control Kit receive FDA 510(k) clearance?
cobas BKV, cobas EBV/BKV Control Kit, cobas Buffer Negative Control Kit received FDA 510(k) clearance on 2020-09-02, under 510(k) number K202215.
Who is the listed applicant for cobas BKV, cobas EBV/BKV Control Kit, cobas Buffer Negative Control Kit?
The FDA 510(k) record lists Roche Molecular Systems, Inc. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for cobas BKV, cobas EBV/BKV Control Kit, cobas Buffer Negative Control Kit?
The FDA product code for cobas BKV, cobas EBV/BKV Control Kit, cobas Buffer Negative Control Kit is QMI.
Other records listing Roche Molecular Systems, Inc. as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: QMI)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.